These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2598566)

  • 1. Pharmacokinetics and pharmacodynamics of atenolol in children.
    Buck ML; Wiest D; Gillette PC; Trippel D; Krull J; O'Neal W
    Clin Pharmacol Ther; 1989 Dec; 46(6):629-33. PubMed ID: 2598566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption pharmacokinetics of atenolol in patients with the Marfan syndrome.
    Phelps SJ; Alpert BS; Ward JL; Pieper JA; Lima JJ
    J Clin Pharmacol; 1995 Mar; 35(3):268-74. PubMed ID: 7608315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of esmolol in children.
    Wiest DB; Trippel DL; Gillette PC; Garner SS
    Clin Pharmacol Ther; 1991 Jun; 49(6):618-23. PubMed ID: 1676357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of fluconazole in immune-compromised children with leukemia or other hematologic diseases.
    Seay RE; Larson TA; Toscano JP; Bostrom BC; O'Leary MC; Uden DL
    Pharmacotherapy; 1995; 15(1):52-8. PubMed ID: 7739946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic studies with atenolol in the dog.
    McAinsh J; Holmes BF
    Biopharm Drug Dispos; 1983; 4(3):249-61. PubMed ID: 6626700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procainamide elimination kinetics in pediatric patients.
    Singh S; Gelband H; Mehta AV; Kessler K; Casta A; Pickoff AS
    Clin Pharmacol Ther; 1982 Nov; 32(5):607-11. PubMed ID: 7128001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiologic properties of intravenous Tenormine in man.
    Di Biase M; Favale S; Rizzon P
    Eur J Cardiol; 1979 Apr; 9(4):333-42. PubMed ID: 34520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of the enantiomers of atenolol.
    Boyd RA; Chin SK; Don-Pedro O; Williams RL; Giacomini KM
    Clin Pharmacol Ther; 1989 Apr; 45(4):403-10. PubMed ID: 2702798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum.
    Hebert MF; Carr DB; Anderson GD; Blough D; Green GE; Brateng DA; Kantor E; Benedetti TJ; Easterling TR
    J Clin Pharmacol; 2005 Jan; 45(1):25-33. PubMed ID: 15601802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and absolute bioavailability of atenolol.
    Mason WD; Winer N; Kochak G; Cohen I; Bell R
    Clin Pharmacol Ther; 1979 Apr; 25(4):408-15. PubMed ID: 428185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of esmolol in pediatric subjects with supraventricular arrhythmias.
    Adamson PC; Rhodes LA; Saul JP; Dick M; Epstein MR; Moate P; Boston R; Schreiner MS
    Pediatr Cardiol; 2006; 27(4):420-7. PubMed ID: 16835806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
    Wójcicki J; Jaroszynska M; Droździk M; Pawlik A; Gawrońska-Szklarz B; Sterna R
    Biopharm Drug Dispos; 2003 Jul; 24(5):211-8. PubMed ID: 12784321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics and pharmacodynamics of tablet, suspension and paste formulations of atenolol in cats.
    Khor KH; Campbell FE; Charles BG; Norris RL; Greer RM; Rathbone MJ; Mills PC
    J Vet Pharmacol Ther; 2012 Oct; 35(5):437-45. PubMed ID: 21985149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
    Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of atenolol in clinically normal cats.
    Quiñones M; Dyer DC; Ware WA; Mehvar R
    Am J Vet Res; 1996 Jul; 57(7):1050-3. PubMed ID: 8807020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the electrophysiological properties of atenolol and of the combination of quinidine and atenolol in humans].
    Capucci A; Verardi P; Binetti G; Bracchetti D; Ambrosioni E; Magnani B
    Boll Soc Ital Cardiol; 1979; 24(10):1059-64. PubMed ID: 261887
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of Atenolol and Propranolol on sinus node and intracardiac conduction in man (author's transl)].
    Seipel L; Breithardt G; Döhring HP
    Z Kardiol; 1977 Dec; 66(12):719-25. PubMed ID: 602355
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical electrophysiological effects of atenolol--a new cardioselective beta-blocking agent.
    Robinson C; Birkhead J; Crook B; Jennings K; Jewitt D
    Br Heart J; 1978 Jan; 40(1):14-21. PubMed ID: 341927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic properties of atenolol in acute myocardial infarction.
    Held P; Regårdh CG; Swedberg K
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):172-4. PubMed ID: 1688977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
    Gordi T; Frohna P; Sun HL; Wolff A; Belardinelli L; Lieu H
    Clin Pharmacokinet; 2006; 45(12):1201-12. PubMed ID: 17112296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.